Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Tadalafil NDC 43598-578 by Dr.reddys Laboratories Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a table related to drug interactions with CYP3A substrates and specifically the drug Digoxin. The table shows different parameters including AUC (Area Under the Curve), Cmax (Maximum Concentration), and Fold Change with 90% Confidence Limits. The table suggests that there is no need for dose adjustment for Digoxin in most cases when coadministered with other drugs listed in the table. The numbers in the table seem to represent dosages of the coadministered drugs.*
This text seems to be a comparison chart of different drugs and their effectiveness when co-administered with Tadalafil. It shows which drugs may inhibit or induce enzymes (CYPaA) that metabolize Tadalafil and cause a change in its effectiveness. The chart includes fold change and 90% Cl (confidence interval) for each drug and suggests whether a dose adjustment is necessary or not. However, the data seems incomplete without headings and proper formatting, and it may not be useful for medical practitioners without additional information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.